51,436 Shares in Teleflex Incorporated $TFX Bought by Capital Fund Management S.A.

Key Points

• Capital Fund Management S.A. purchased a new stake in Teleflex Incorporated, acquiring 51,436 shares valued at approximately $7.1 million, representing about 0.12% of the company.
• Wall Street analysts have given Teleflex a consensus rating of "Hold", with an average price target of $141.57, reflecting mixed sentiments from recent research reports.
• The company reported a $3.73 EPS for the last quarter, exceeding forecasts, and announced a quarterly dividend of $0.34 per share, set to be paid on September 15th.

Capital Fund Management S.A. bought a new position in Teleflex Incorporated (NYSE:TFX - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 51,436 shares of the medical technology company's stock, valued at approximately $7,108,000. Capital Fund Management S.A. owned approximately 0.12% of Teleflex as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Teacher Retirement System of Texas purchased a new stake in shares of Teleflex in the 1st quarter worth about $1,242,000. Amalgamated Bank grew its stake in shares of Teleflex by 56.9% in the 1st quarter. Amalgamated Bank now owns 14,046 shares of the medical technology company's stock worth $1,941,000 after buying an additional 5,095 shares during the last quarter. New York State Teachers Retirement System increased its position in Teleflex by 13.9% during the 1st quarter. New York State Teachers Retirement System now owns 45,063 shares of the medical technology company's stock valued at $6,227,000 after buying an additional 5,482 shares in the last quarter. Brown Advisory Inc. increased its position in Teleflex by 34.2% during the 1st quarter. Brown Advisory Inc. now owns 2,524 shares of the medical technology company's stock valued at $349,000 after buying an additional 643 shares in the last quarter. Finally, CX Institutional purchased a new position in Teleflex during the first quarter valued at $105,000. 95.62% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the company. Truist Financial cut their target price on Teleflex from $140.00 to $137.00 and set a "hold" rating on the stock in a research note on Monday, May 5th. Wells Fargo & Company dropped their price target on shares of Teleflex from $137.00 to $131.00 and set an "equal weight" rating on the stock in a research note on Friday, August 1st. Mizuho increased their price objective on shares of Teleflex from $130.00 to $135.00 and gave the company a "neutral" rating in a research report on Friday, August 1st. Morgan Stanley decreased their target price on shares of Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a report on Monday, May 5th. Finally, Wall Street Zen upgraded shares of Teleflex from a "hold" rating to a "strong-buy" rating in a report on Saturday, August 2nd. One investment analyst has rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $141.57.

Teleflex Stock Performance

NYSE:TFX traded down $3.55 during mid-day trading on Thursday, hitting $125.95. 101,959 shares of the company traded hands, compared to its average volume of 782,508. Teleflex Incorporated has a one year low of $108.90 and a one year high of $249.90. The company has a quick ratio of 1.44, a current ratio of 2.41 and a debt-to-equity ratio of 0.42. The stock's fifty day moving average price is $118.71 and its 200-day moving average price is $130.01. The firm has a market cap of $5.57 billion, a price-to-earnings ratio of 29.61, a price-to-earnings-growth ratio of 1.77 and a beta of 1.08.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.36 by $0.37. The business had revenue of $780.90 million for the quarter, compared to the consensus estimate of $771.53 million. Teleflex had a return on equity of 15.08% and a net margin of 6.31%.The business's revenue was up 4.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $3.42 EPS. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. Research analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 15th. Shareholders of record on Friday, August 15th will be paid a dividend of $0.34 per share. The ex-dividend date is Friday, August 15th. This represents a $1.36 dividend on an annualized basis and a yield of 1.1%. Teleflex's dividend payout ratio is 32.00%.

Insider Transactions at Teleflex

In other news, Director Stuart A. Randle acquired 1,000 shares of Teleflex stock in a transaction dated Tuesday, August 5th. The shares were acquired at an average cost of $115.86 per share, for a total transaction of $115,860.00. Following the acquisition, the director owned 7,547 shares of the company's stock, valued at $874,395.42. This trade represents a 15.27% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Gretchen R. Haggerty bought 500 shares of the company's stock in a transaction that occurred on Wednesday, August 6th. The stock was acquired at an average cost of $114.75 per share, for a total transaction of $57,375.00. Following the acquisition, the director directly owned 6,305 shares of the company's stock, valued at $723,498.75. The trade was a 8.61% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought a total of 5,500 shares of company stock valued at $633,590 in the last 90 days. Insiders own 1.40% of the company's stock.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.